Nebula Research & Development LLC Health Catalyst, Inc. Transaction History
Nebula Research & Development LLC
- $836 Billion
- Q3 2024
A detailed history of Nebula Research & Development LLC transactions in Health Catalyst, Inc. stock. As of the latest transaction made, Nebula Research & Development LLC holds 56,001 shares of HCAT stock, worth $477,128. This represents 0.05% of its overall portfolio holdings.
Number of Shares
56,001
Previous 36,038
55.39%
Holding current value
$477,128
Previous $230 Million
97.95%
% of portfolio
0.05%
Previous 0.04%
Shares
4 transactions
Others Institutions Holding HCAT
# of Institutions
170Shares Held
49.7MCall Options Held
2.86MPut Options Held
56.4K-
Black Rock Inc. New York, NY5.43MShares$46.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.58MShares$39 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN4.3MShares$36.6 Million3.05% of portfolio
-
Impax Asset Management Group PLC2.55MShares$21.8 Million0.09% of portfolio
-
Daventry Group, LP New York, NY2.42MShares$20.6 Million7.83% of portfolio
About Health Catalyst, Inc.
- Ticker HCAT
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 54,723,400
- Market Cap $466M
- Description
- Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accura...